Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Marinomed, Zumtobel (11/10/2024)

13.10.2024

Marinomed: Marinomed Biotech AG announced that, after a thorough review of existing offers, the Management Board today decided to enter contract negotiations for the sale of the Carragelose portfolio in the form of an asset deal. The Company selected the potential buyer based on a combination of favorable purchase price, transaction security and strategic fit, thereby providing a long-term perspective for the Company. The actual implementation of the transaction depends on the outcome of the specific negotiations, the conclusion of the respective transaction documents, the approval of the Supervisory Board and the General Shareholder Assembly, as well as the continuation of the Company after the restructuring process. In addition, due to the ongoing restructuring process, approvals from the insolvency administrator and the insolvency court are necessary. These approvals have not yet been obtained.

Zumtobel: The Supervisory Board of the Zumtobel Group has extended the contract of Chief Executive Officer Alfred Felder (61), which is due to expire as of 31 July 2025, until 30 September 2027. With the repeated renewal of his contract, the Supervisory Board focuses on continuity in the Management Board of the Zumtobel Group and recognises the achievements of Alfred Felder, who has navigated the company through difficult times. On 1 February 2018, Alfred Felder took over the role of Acting President of the Management Board; on 8 June 2018, he was appointed Chief Executive Officer (CEO).
Zumtobel: weekly performance: 0.36%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/10/2024)


Partners









latest 21st Austria

21st Austria weekly - Marinomed, Zumtobel (11/10/2024)


13.10.2024, 1628 Zeichen



Marinomed: Marinomed Biotech AG announced that, after a thorough review of existing offers, the Management Board today decided to enter contract negotiations for the sale of the Carragelose portfolio in the form of an asset deal. The Company selected the potential buyer based on a combination of favorable purchase price, transaction security and strategic fit, thereby providing a long-term perspective for the Company. The actual implementation of the transaction depends on the outcome of the specific negotiations, the conclusion of the respective transaction documents, the approval of the Supervisory Board and the General Shareholder Assembly, as well as the continuation of the Company after the restructuring process. In addition, due to the ongoing restructuring process, approvals from the insolvency administrator and the insolvency court are necessary. These approvals have not yet been obtained.

Zumtobel: The Supervisory Board of the Zumtobel Group has extended the contract of Chief Executive Officer Alfred Felder (61), which is due to expire as of 31 July 2025, until 30 September 2027. With the repeated renewal of his contract, the Supervisory Board focuses on continuity in the Management Board of the Zumtobel Group and recognises the achievements of Alfred Felder, who has navigated the company through difficult times. On 1 February 2018, Alfred Felder took over the role of Acting President of the Management Board; on 8 June 2018, he was appointed Chief Executive Officer (CEO).
Zumtobel: weekly performance: 0.36%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (11/10/2024)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Martin Bechtloff (Franklin Templeton): "Immer mehr Investoren beurteilen ihr China-Exposure separat"




 

Bildnachweis

Aktien auf dem Radar:voestalpine, Pierer Mobility, Warimpex, Addiko Bank, CA Immo, Immofinanz, Verbund, ATX, ATX Prime, ATX TR, Bawag, Andritz, Österreichische Post, AT&S, Cleen Energy, Frauenthal, Kostad, Oberbank AG Stamm, Kapsch TrafficCom, DO&CO, Agrana, Amag, Erste Group, EVN, Flughafen Wien, OMV, Palfinger, RHI Magnesita, Semperit, S Immo, Telekom Austria.


Random Partner

CA Immo
CA Immo ist der Spezialist für Büroimmobilien in zentraleuropäischen Hauptstädten. Das Unternehmen deckt die gesamte Wertschöpfungskette im gewerblichen Immobilienbereich ab: Vermietung und Management sowie Projektentwicklung mit hoher in-house-Baukompetenz. Das 1987 gegründete Unternehmen notiert im ATX der Wiener Börse.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten